MYEL-CD180NCT07895901
Characterization of CD180 Protein Expression in Myeloid Hematological Malignancies by Flow Cytometry
StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
CD180 Expression in Normal and Pathological CD34+ Cells
Timeframe: During the 6-month data collection period, from January 21, 2026, to July 21, 2027.
Sites
1 site in 1 country
- Laboratoire d'Hématologie Biologique - CHU de Strasbourg - FranceStrasbourg, France